Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Decibel Therapeutics Inc (NQ: DBTX ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Decibel Therapeutics Inc < Previous 1 2 3 Next > DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX September 05, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - August 31, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sovos Brands, Inc. (Nasdaq - SOVO), Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. August 24, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ElectraMeccanica (Nasdaq - SOLO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX) August 15, 2023 From Brodsky & Smith LLC Via GlobeNewswire DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX August 12, 2023 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet August 11, 2023 Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be... Via Benzinga Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update August 11, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023 August 10, 2023 Via Benzinga Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday August 10, 2023 Keybanc cut the price target for i3 Verticals, Inc. (NASDAQ: IIIV) from $28 to $26. Keybanc analyst Josh Beck maintained an Overweight rating. i3 Verticals shares fell 2.9% to close at $22.76 on... Via Benzinga Dow Edges Higher; Tigo Energy Shares Plunge August 09, 2023 U.S. stocks pared some losses toward the end of trading, with the Dow Jones turning higher on Wednesday. The Dow traded up 0.05% to 35,332.35 while the NASDAQ fell 0.46% to 13,820.37. The S&P 500, also... Via Benzinga Topics Stocks Exposures US Equities Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session August 09, 2023 Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. Via Benzinga Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday August 09, 2023 U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Intraday Session August 09, 2023 Via Benzinga Nasdaq Down 1%; Decibel Therapeutics Shares Spike Higher August 09, 2023 U.S. stocks were lower midway through trading, with the Nasdaq Composite falling around 1% on Wednesday. The Dow traded down 0.52% to 35,130.45 while the NASDAQ fell 1.03% to 13,741.71. The S&P 500,... Via Benzinga Topics Stocks Exposures US Equities Health Care Company Regeneron Pharmaceuticals Announces Acquisition of Decibel Therapeutics August 09, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023 August 09, 2023 Via Benzinga Why Is Tango Therapeutics (TNGX) Stock Up 117% Today? August 09, 2023 Tango Therapeutics (TNGX) stock is soaring higher on Wednesday after getting a couple of updates from analysts covering the shares. Via InvestorPlace YELL Stock Alert: Yellow Receives Nasdaq Delisting Notice August 09, 2023 Yellow (YELL) stock is falling on Wednesday after the struggling U.S. trucking company received a Nasdaq delisting notice! Via InvestorPlace DBTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Decibel Therapeutics, Inc. Is Fair to Shareholders August 09, 2023 From Halper Sadeh LLC Via Business Wire US Stocks Edge Lower; Charles River Earnings Top Estimates August 09, 2023 U.S. stocks were mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.03% to 35,303.64 while the... Via Benzinga Decibel Therapeutics (DBTX) Stock Skyrockets 71% on Regeneron Deal August 09, 2023 Decibel Therapeutics (DBTX) stock is soaring higher on Wednesday after signing a deal with Regeneron Pharmaceuticals (REGN). Via InvestorPlace Decibel Therapeutics Stock Soars on Acquisition Deal - The Details August 09, 2023 Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has agreed to acquire Decibel Therapeutics Inc (NASDAQ: DBTX) at $4.00 per share with an additional contingent value right of up to $3.50 per share in cash... Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX) August 09, 2023 From Brodsky & Smith LLC Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session August 09, 2023 Via Benzinga Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs August 09, 2023 From Regeneron Pharmaceuticals, Inc.; Decibel Therapeutics, Inc. Via GlobeNewswire Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference June 02, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting June 01, 2023 Data from interim analysis support DB-020 as a potential therapy to protect patients against irreversible hearing loss associated with cisplatin chemotherapy From Decibel Therapeutics, Inc. Via GlobeNewswire Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit May 17, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update May 15, 2023 From Decibel Therapeutics, Inc. Via GlobeNewswire Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO May 12, 2023 CTA authorization provides approval for the Company to expand its planned CHORD™ Phase 1/2 clinical trial of DB-OTO to patients in Spain aged two years and younger From Decibel Therapeutics, Inc. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
